Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06932302 · ClinicalTrials.gov registry record · NA
At-Home Neuromodulation for Female Sexual Dysfunction
A NA study of Female Sexual Dysfunction, sponsored by University of Michigan.
- Recruiting
- Registry status
- NA
- Development phase
- 24
- Enrollment target
- 1
- Study location
NCT06932302: Recruiting NA study of Female Sexual Dysfunction, sponsored by University of Michigan.
NCT06932302 is a NA study of Female Sexual Dysfunction that is actively recruiting participants, run by University of Michigan. The registered enrollment target is 24 participants, below the 84-participant average among 4 other Female Sexual Dysfunction trials with a reported enrollment target (71% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06932302, a NA study of Female Sexual Dysfunction, is actively recruiting participants, sponsored by University of Michigan.
- RECRUITING
- Registry status
- NA
- Development phase
- 24 participants
- Enrollment target
- 1
- Study location
Study Summary
This pilot study investigates the regular use of non-invasive dorsal genital nerve stimulation (DGS) for the treatment of female sexual dysfunction (FSD). The researchers aim to determine whether subjects with FSD can correctly follow an at-home treatment regimen and to demonstrate that DGS can improve FSD arousal symptoms in premenopausal and postmenopausal women. Some subjects will use a smart vibrator for comparison to DGS.
Conditions Studied
Interventions
- DEVICE Electrical Stimulation
- DEVICE Smart vibrator
Study Locations (1)
Michigan
- University of Michigan - Ann Arbor
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2025-10-15 |
| Est. Completion | 2027-11 |
| Phase | NA |
What NCT06932302 shows while recruiting
NCT06932302 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 24 participants, a relatively small participant target, below the 84-participant average among 4 other Female Sexual Dysfunction trials with a reported enrollment target (71% lower).
The record links to 1 condition, with Female Sexual Dysfunction appearing as the primary indexed condition, and to 2 interventions - of which Electrical Stimulation is the first listed.
NCT06932302 reports a single indexed study location in Michigan.
Frequently Asked Questions
What is clinical trial NCT06932302 about?
NCT06932302 is a clinical study titled "At-Home Neuromodulation for Female Sexual Dysfunction". This pilot study investigates the regular use of non-invasive dorsal genital nerve stimulation (DGS) for the treatment of female sexual dysfunction (FSD). The researchers aim to determine whether subjects with FSD can correctly follow an at-home treatment regimen and to demonstrate that DGS can impr...
What is the current status of trial NCT06932302?
This trial is currently recruiting. It is a NA study. The enrollment target is 24 participants. The study started on 2025-10-15. Estimated completion is 2027-11.
What conditions does trial NCT06932302 study?
This clinical trial studies the following conditions: Female Sexual Dysfunction.
What interventions are being tested in trial NCT06932302?
The interventions under investigation include: Electrical Stimulation (DEVICE), Smart vibrator (DEVICE).
Who is sponsoring clinical trial NCT06932302?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06932302 being conducted?
This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Female Sexual Dysfunction
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Evaluation of Vitamin D in Women With PCOS and Sexual Dysfunction
COMPLETED · NA
-
A Mindfulness-based Intervention for Older Women With Low Sexual Desire
COMPLETED · NA
-
Trial of Tibial Nerve Stimulation for Treating Sexual Dysfunction
COMPLETED · NA
-
Effect of Intradetrusor onabotulinumtoxinA Injection Versus Conservative Management on Female Sexual Function in Patients With Bladder Pain Syndrome
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02331979 · 24 participants · NA
Improving Bladder Function in SCI by Neuromodulation
- NCT03096197 · 24 participants · NA
Exoskeleton and Spinal Cord Stimulation for SCI
- NCT03223922 · 24 participants · NA
Neurocognitive Functioning With Genu-Sparing Whole Brain Radiation Therapy for Brain Metastases
- NCT03326921 · 24 participants · Phase 1
HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI